Overview

Analyzing the Pharmacodynamic Substances and the Effects of Xingnaojing for Mild-to-Severe Acute Ischemic Stroke

Status:
Recruiting

Trial end date:
2023-03-31

Target enrollment:

Participant gender:

Summary

The main purposes of this trial are to analyze the pharmacodynamic substances and the effects of Xingnaojing for mild-to-severe acute ischemic stroke.

Phase:

Phase 4

Details

Lead Sponsor:

Ying Gao

Collaborator:

Beijing Chaoyang Integrative Medicine Rescue and First Aid Hospital